Three out of every 10 people in this country who have type 2 diabetes inject insulin. But sadly, few people start on it.
Many people with type 2 diabetes think that taking insulin is only for people with type 1 diabetes and for those people with type 2 who have failed to manage their blood glucose with everything else. A survey of Australian adults with type 2 diabetes found that more than half believe that taking insulin means their diabetes has become worse and that insulin causes weight gain. Among Americans, the results are likely to be similar.
The majority of those people with these negative beliefs about insulin were wrong to think that taking insulin was the diabetes drug of last resort. Actually, insulin may give you the most control over your diabetes, if you aren’t ready yet to go on a very low-carb diet. And for several years some clinics have been prescribing insulin soon after diagnosis. It works.
But the people with type 2 diabetes with negative opinions about insulin were right to think that taking insulin usually leads to gaining weight.
My second book
Ten years ago when I wrote my second book, “Losing Weight with Your Diabetes Medication,” I emphasized that people with type 2 diabetes typically gain weight when they take insulin and cited two studies.
In one of these studies, 458 people with type 2 diabetes used insulin for six years, gaining more than 22 pounds. In the other study, people with type 2 diabetes gained more than 7 pounds in the first year alone.
A subsequent study of 2,272 people with type 2 diabetes from 12 countries found that after four years they had gained an average of 17 pounds. They added most of it—11 pounds—in the first year. But the amount of weight gain from insulin injections depended largely on the type of insulin that people use.
Another subsequent study of 7,759 people with type 2 diabetes was a meta-analysis of 16 randomized controlled trials. This study compared how different insulin regimes on affected body weight. It suggested that the lowest weight gain was seen with basal insulin.
The new study
A large study has now confirmed that people with type 2 diabetes typically gain only a little weight when they use a basal insulin. This prospective observational study involved about 200 physician offices in Germany that specialize in the care of people with type 2 diabetes.
The study identified 98,586 people with type 2 diabetes. A group of 113 people began their diabetes management by taking basal insulin, which the study identified as insulin glargine (Lantus, Toujeo, and Basaglar), insulin detemir (Levemir), and neutral protamine Hagedorn (NPH). Novo Nordisk sells NPH as Novolin N and Lilly as Humulin N.
Small weight gain
After a year on one of these basal insulins, the people with type 2 diabetes in this study averaged a much smaller weight gain than those in the earlier studies, which were of all the different insulin regimes. The people in the new study typically gained just over 2 pounds in their first year. The variation among the three types of basal insulin—glargine, detemir, and NPH—was “modest,” the study reported.
In the year that the researchers studied the basal insulin group, the people with type 2 diabetes made substantial reductions in their blood glucose levels. Their A1C levels dropped 1.8 percent, which typically meant reducing their A1C levels from 8.6 to 6.8.
The study’s aims
This new study had two aims. The first was to find the amount of weight gain the people had when they started basal insulin early after diagnosis. The second aim was to find what caused this weight gain.
The study’s authors suggested why the people in the new study gained so little weight compared with those in earlier studies of insulin use. In earlier studies, blood glucose typically had “already risen to an extreme level.” The people in the new study started with an average A1C of 8.6 and began taking insulin soon after they were diagnosed with diabetes.
Start basal insulin right after diagnosis
This new study confirms one that I reported here in 2014. Start basal insulin as soon as you know that you have type 2 diabetes. Taking it—far from being a strategy of last resort—needs to be you first resort.
See More Helpful Articles:
David Mendosa is a journalist who learned in 1994 that he has type 2 diabetes, which he now writes about exclusively. He has written thousands of diabetes articles, two books about it, created one of the first diabetes websites, and publishes the monthly newsletter, “Diabetes Update.” His very low-carbohydrate diet, current A1C level of 5.3, and BMI of 19.8 keep his diabetes in remission without any drugs. He can be found on Twitter @davidmendosa and on Facebook at David Mendosa.
David Mendosa was a journalist who learned in 1994 that he had type 2 diabetes, which he wrote about exclusively. He died in May 2017 after a short illness unrelated to diabetes. He wrote thousands of diabetes articles, two books about it, created one of the first diabetes websites, and published a monthly newsletter, “Diabetes Update.” His very low-carbohydrate diet, A1C level of 5.3, and BMI of 19.8 kept his diabetes in remission without any drugs until his death.